WO1999034758A1 - Technique for using brain heat flow management to treat brain disorders - Google Patents
Technique for using brain heat flow management to treat brain disorders Download PDFInfo
- Publication number
- WO1999034758A1 WO1999034758A1 PCT/US1999/000374 US9900374W WO9934758A1 WO 1999034758 A1 WO1999034758 A1 WO 1999034758A1 US 9900374 W US9900374 W US 9900374W WO 9934758 A1 WO9934758 A1 WO 9934758A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- brain
- heat transfer
- sensor elements
- heat
- management unit
- Prior art date
Links
- 210000004556 brain Anatomy 0.000 title claims abstract description 111
- 238000000034 method Methods 0.000 title claims abstract description 52
- 208000014644 Brain disease Diseases 0.000 title claims abstract description 15
- 238000012546 transfer Methods 0.000 claims abstract description 72
- 230000000694 effects Effects 0.000 claims abstract description 51
- 238000001816 cooling Methods 0.000 claims abstract description 36
- 210000005013 brain tissue Anatomy 0.000 claims abstract description 24
- 230000002159 abnormal effect Effects 0.000 claims abstract description 15
- 230000007177 brain activity Effects 0.000 claims abstract description 11
- 210000003625 skull Anatomy 0.000 claims abstract description 10
- 238000005520 cutting process Methods 0.000 claims abstract description 8
- 206010010904 Convulsion Diseases 0.000 claims description 104
- 230000000638 stimulation Effects 0.000 claims description 32
- 239000003814 drug Substances 0.000 claims description 24
- 230000002631 hypothermal effect Effects 0.000 claims description 23
- 206010015037 epilepsy Diseases 0.000 claims description 20
- 210000000056 organ Anatomy 0.000 claims description 18
- 230000008961 swelling Effects 0.000 claims description 14
- 210000001519 tissue Anatomy 0.000 claims description 14
- 206010061218 Inflammation Diseases 0.000 claims description 11
- 230000004054 inflammatory process Effects 0.000 claims description 11
- 238000001802 infusion Methods 0.000 claims description 10
- 208000002193 Pain Diseases 0.000 claims description 9
- 229940124597 therapeutic agent Drugs 0.000 claims description 9
- 210000001103 thalamus Anatomy 0.000 claims description 8
- 210000000278 spinal cord Anatomy 0.000 claims description 7
- 210000000133 brain stem Anatomy 0.000 claims description 6
- 210000003169 central nervous system Anatomy 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 6
- 210000001320 hippocampus Anatomy 0.000 claims description 6
- 230000006698 induction Effects 0.000 claims description 6
- 230000036407 pain Effects 0.000 claims description 6
- 230000004936 stimulating effect Effects 0.000 claims description 6
- 238000007920 subcutaneous administration Methods 0.000 claims description 5
- 238000010792 warming Methods 0.000 claims description 5
- 210000004727 amygdala Anatomy 0.000 claims description 4
- 210000001638 cerebellum Anatomy 0.000 claims description 4
- 230000000977 initiatory effect Effects 0.000 claims description 4
- 210000000478 neocortex Anatomy 0.000 claims description 4
- 208000032843 Hemorrhage Diseases 0.000 claims description 3
- 208000004404 Intractable Pain Diseases 0.000 claims description 3
- 208000019695 Migraine disease Diseases 0.000 claims description 3
- 206010027603 Migraine headaches Diseases 0.000 claims description 3
- 208000016285 Movement disease Diseases 0.000 claims description 3
- 208000003926 Myelitis Diseases 0.000 claims description 3
- 210000001015 abdomen Anatomy 0.000 claims description 3
- 239000000919 ceramic Substances 0.000 claims description 3
- 206010014599 encephalitis Diseases 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 208000014674 injury Diseases 0.000 claims description 3
- 230000003902 lesion Effects 0.000 claims description 3
- 230000008733 trauma Effects 0.000 claims description 3
- 229940121891 Dopamine receptor antagonist Drugs 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 230000003187 abdominal effect Effects 0.000 claims description 2
- 229940035674 anesthetics Drugs 0.000 claims description 2
- 210000004227 basal ganglia Anatomy 0.000 claims description 2
- 229940049706 benzodiazepine Drugs 0.000 claims description 2
- 150000001557 benzodiazepines Chemical class 0.000 claims description 2
- 239000003210 dopamine receptor blocking agent Substances 0.000 claims description 2
- 239000003136 dopamine receptor stimulating agent Substances 0.000 claims description 2
- 210000003195 fascia Anatomy 0.000 claims description 2
- 239000003193 general anesthetic agent Substances 0.000 claims description 2
- 239000003823 glutamate receptor agonist Substances 0.000 claims description 2
- 239000003825 glutamate receptor antagonist Substances 0.000 claims description 2
- 150000001469 hydantoins Chemical class 0.000 claims description 2
- 210000003016 hypothalamus Anatomy 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 208000020016 psychiatric disease Diseases 0.000 claims description 2
- 239000000018 receptor agonist Substances 0.000 claims description 2
- 229940044601 receptor agonist Drugs 0.000 claims description 2
- 229940044551 receptor antagonist Drugs 0.000 claims description 2
- 239000002464 receptor antagonist Substances 0.000 claims description 2
- 229910052814 silicon oxide Inorganic materials 0.000 claims description 2
- 210000002027 skeletal muscle Anatomy 0.000 claims description 2
- 210000000115 thoracic cavity Anatomy 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 238000007726 management method Methods 0.000 description 20
- 238000011282 treatment Methods 0.000 description 16
- 229940079593 drug Drugs 0.000 description 15
- 206010042674 Swelling Diseases 0.000 description 10
- 238000010304 firing Methods 0.000 description 8
- 230000002739 subcortical effect Effects 0.000 description 7
- 241000700159 Rattus Species 0.000 description 5
- 230000001054 cortical effect Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000001537 neural effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 210000004958 brain cell Anatomy 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 238000000537 electroencephalography Methods 0.000 description 4
- 230000000971 hippocampal effect Effects 0.000 description 4
- 238000005086 pumping Methods 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229930195712 glutamate Natural products 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 102000005915 GABA Receptors Human genes 0.000 description 2
- 108010005551 GABA Receptors Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010033664 Panic attack Diseases 0.000 description 2
- 206010061334 Partial seizures Diseases 0.000 description 2
- 230000005679 Peltier effect Effects 0.000 description 2
- 208000028017 Psychotic disease Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000013528 artificial neural network Methods 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 208000028683 bipolar I disease Diseases 0.000 description 2
- 208000031513 cyst Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000002397 epileptogenic effect Effects 0.000 description 2
- 230000002964 excitative effect Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000001709 ictal effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 208000019906 panic disease Diseases 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- 230000007384 vagal nerve stimulation Effects 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 208000014094 Dystonic disease Diseases 0.000 description 1
- 102100031560 Excitatory amino acid transporter 3 Human genes 0.000 description 1
- 101000866302 Homo sapiens Excitatory amino acid transporter 3 Proteins 0.000 description 1
- 241001316086 Novocrania Species 0.000 description 1
- 208000020307 Spinal disease Diseases 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 210000001159 caudate nucleus Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- -1 deoxybarbiturates Chemical class 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 208000010118 dystonia Diseases 0.000 description 1
- 208000028329 epileptic seizure Diseases 0.000 description 1
- 230000001787 epileptiform Effects 0.000 description 1
- 230000008579 epileptogenesis Effects 0.000 description 1
- 230000001667 episodic effect Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000021824 exploration behavior Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000001535 kindling effect Effects 0.000 description 1
- 210000003140 lateral ventricle Anatomy 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001423 neocortical effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008587 neuronal excitability Effects 0.000 description 1
- 230000008062 neuronal firing Effects 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 210000000929 nociceptor Anatomy 0.000 description 1
- 108091008700 nociceptors Proteins 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000003523 substantia nigra Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000003461 thalamocortical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000001515 vagal effect Effects 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36135—Control systems using physiological parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00084—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22082—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0002—Head or parts thereof
- A61F2007/0008—Scalp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/007—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating
- A61F2007/0075—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating using a Peltier element, e.g. near the spot to be heated or cooled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/007—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating
- A61F2007/0077—Details of power supply
- A61F2007/0078—Details of power supply with a battery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0095—Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0295—Compresses or poultices for effecting heating or cooling for heating or cooling or use at more than one temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
- A61F2007/126—Devices for heating or cooling internal body cavities for invasive application, e.g. for introducing into blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36064—Epilepsy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36071—Pain
- A61N1/36075—Headache or migraine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
Definitions
- the invention pertains to acute methods of treating a brain disorder using heat transfer to improve brain function.
- Heat transfer may be combined with electrical stimulation of the brain or direct infusion of therapeutic agents into the brain to reduce or prevent the occurrence of, for example, an epileptic seizure.
- the method may also be used for brain disorders other than epilepsy, for spinal disorders, and for disorders of other body organs and tissues.
- Epilepsy is a significant medical problem, as nearly 1 % of the United States population is affected by this disease at any given time, constituting about 2.6 million people. The incidence of epilepsy is higher in children and in the elderly, such that approximately 3.5% of the population will have epilepsy at some point in life. ' ' ' . Seizures are controllable in 70% of patients, but about 30% of patients have seizures refractory to treatment. Estimates indicate that the total lifetime costs in 1990 dollars for all of those with epilepsy newly diagnosed just in 1990 will be 3 billion dollars with slightly over 1 billion of this direct costs and the rest indirect costs. For those having controllable seizures, the cost per patient will be slightly over $4000.
- Epileptic seizures occur because of an abnormal intensity and synchronized firing of brain cells.
- Generalized seizures can begin over essentially the entire brain at one time, while others, known as focal or partial seizures, begin in a localized area of the brain and then spread.
- focal or partial seizures occur in a localized area of the brain and then spread.
- both widespread and localized mechanisms appear to be involved in the occurrence of seizures.
- seizures manifest themselves as seizure discharges affecting the cerebral cortex, the outer most layer of the brain, though paradoxically, stimulation of the thalamus and other subcortical regions, located deeper within the brain, have been shown to not only initiate but also control or even prevent seizures.
- vagal nerve stimulation for treatment of some seizures.
- the vagus nerve is located in the neck and extends to the brain stem from which it has widespread connections within the brain, including branches to the thalamus 32; 22 .
- a vagal nerve simulator has recently been released as a commercial product. Information thus far indicates that it is moderately effective, but only rarely controls seizures completely.
- seizures are sufficiently localized such that removal of a particular area of the brain may result in complete seizure control".
- Electrical stimulation provides a non-surgical means for impairing generation of localized seizures " ' ' ' .
- drug application to a seizure focus can suppress or eliminate seizure activity 10 '
- Hypothermia is known to have a protective effect on the brain both in experimental animal preparations and in humans This protective effect on the brain is one of the reasons for employing hypothermia in medical procedures, such as cardiac surgery 6 .
- Hypothermia alters the electrical activity of the cortex in models of brain ischemia, and decreases the production of the excitatory neurotransmitters glutamate and dopamine 7 .
- Hypothermia also appears to reduce the occurrence, frequency, and amplitude of cortical potentials and suppresses seizure activity 35, 12 ' 2 ' 40 . Cooling is thought to prevent or abort seizures by reducing cortical excitability. Cooling brain tissue can be safely accomplished when properly undertaken. For example, irrigation of the temporal horn of the lateral ventricle with ice-cold liquid to cool the hippocampus has been successful in acutely altering memory functions in humans with no apparent adverse effects 25 .
- One potential method utilizes neural networks as a means of detecting seizures.
- the advantage of this approach is that the computer detection may be modified to suit the individual patient.
- Implanted electrodes may use an algorithm based on neural networks to detect seizure activity.
- several rule based or template matching methods for seizure detection may be employed, as well as methods modeling seizures as chaotic attractors.
- U.S. Patent number 5,713,923 to Ward et al. discloses techniques for treating epilepsy using a combination of electrical stimulation of the brain and drug infusion to neural tissue. Stimulation may be directed to increase the output of inhibitory structures, such as the cerebellum, thalamus, or brain stem, or may inactivate epileptogenic areas. These methods tend to be based on chronic stimulation of brain inhibitory systems, with the goal of decreasing the background propensity to epileptogenesis. Historically, stimulation of inhibitory structures alone has not been particularly successful in seizure management. Ward '923 uses an implantable electrode to sense seizure onset, which permits regulatable stimulation of the brain during initial seizure activity.
- Ward '923 The combination of drug infusion with brain stimulation as disclosed in Ward '923, would fail to be effective in many types of seizures. Many drugs are not particularly stable at body temperature, rendering them unsuitable for long term storage in an implanted infusion device. Certain risks exist for patients receiving the combined therapy of Ward '923, including an increased risk for seizure propagation due brain stimulation as well as drug related side effects. Thus, while suitable for controlling some seizures, a substantial population of patients have seizures which cannot be treated using the methodology of Ward '923. Therefore, a need exists to improve the therapeutic options available to persons with brain disorders, such as epilepsy.
- An object of the present invention relates to the use of hypothermia for the treatment of brain disorders, comprising a method of treating a brain disorder by heat transfer from brain tissue comprising the steps of: surgically cutting a heat transfer aperture into a patient's skull, thereby exposing a predetermined portion of patient's brain; surgically implanting into said heat transfer aperture a heat pump having one or more activity sensor elements and one or more temperature sensor elements ; surgically implanting a heat transfer management unit in a body cavity of said patient such that a micro controller of the heat transfer management unit is connected to one or more activity sensor elements and one or more temperature sensor elements contacting brain tissue; and connecting the heat transfer management unit to said heat pump via a lead bundle; whereby responsive to signals from said one or more activity or temperature sensor elements, mathematical algorithms of the heat transfer management unit determine abnormal brain activity, causing the heat pump to remove heat from the brain tissue into a heat sink, thereby cooling the predetermined portion of the patient's brain.
- the invention relates to a method of reducing or preventing the occurrence of a seizure comprising cooling brain tissue at or near a seizure focus or a, brain structure that modulates seizures.
- the invention in another preferred embodiment, relates to a method of reducing or preventing the occurrence of a seizure comprising cooling brain tissue and electrically stimulating the brain at or near a seizure focus or a brain structure that modulates seizures.
- the invention relates a method of reducing or preventing the occurrence of a seizure comprising cooling brain tissue and infusing a therapeutic agent into the brain at or near a seizure focus or a brain structure that modulates seizures.
- the invention relates a method of reducing or preventing the occurrence of a seizure comprising cooling brain tissue and electrically stimulating the brain tissue and infusing a therapeutic agent into the brain at or near a seizure focus or a brain structure that modulates seizures.
- the invention provides for placing electrodes in or on the brain area(s) of seizure foci and using mathematical algorithms to detect seizure onset. Once seizure onset is detected, cooling of the brain tissue is initiated to reduce abnormal brain cell firing.
- the electrodes detecting seizure occurrence could be situated on the cortical surface, deeply within cortex inaccessible to a surface electrode, or in deeper, subcortical areas of the brain such as the thalamus. Similarly, cooling and other treatments could occur at the cortex, could occur in subcortical regions, or both.
- the invention provides for multiple techniques that could be applied singly or in combination depending upon the situation of the specific seizure.
- Control of an individual event may require only one of these methods, or may require a combination of two or more procedures involving, for example, hypothermia and drug infusion together with electrical brain stimulation. Because single or combination techniques are provided, the likelihood of seizure control is improved, as therapy may be tailored to individual patient needs. The overall amount of treatment would be decreased to the minimum necessary, as the " method would only treat patients when a seizure is imminent or occurring.
- Yet another preferred embodiment provides for the control of brain disorders such as intractable pain, psychiatric disorders and movement disorders.
- brain disorders such as intractable pain, psychiatric disorders and movement disorders.
- ailments include dystonia or tremor, manic-depressive illness, panic attacks, and psychosis which may manifest themselves by acute changes in behavior.
- Yet another preferred embodiment provides for control of central nervous system swelling and inflammation.
- swelling of brain or spinal tissue due to trauma, hemorrhage, encephalitis or localized myelitis, mass lesions, such as tumors, cysts, and abscesses, and intractable migraine headaches may be controlled by cooling according to the invention.
- Still another preferred embodiment of the invention provides for control of swelling, inflammation or localized pain in non-central nervous system organs.
- FIG. 1 shows the main components of the invention.
- a heat transfer aperture (HTA) is surgically cut into the patient's skull. Thereafter, a heat pump is placed in this aperture.
- the device is located on the brain surface to treat superficial foci, such that the HTA rests on the surface of the section of brain to be treated. Treatment of a portion of the brain below the surface is achieved by placement of the HTA at a convenient location on the brain surface, with tubing leading to the deeper brain area to be treated.
- the relationship of the heat pump to the brain, skull and scalp is shown for the preferred embodiment of the invention.
- a lead bundle connects the heat pump to the heat transfer management unit (HTMU) located in a suitable body cavity.
- HTMU heat transfer management unit
- Fig. 2 shows the heat pump array of Peltier junctions combined with sensor elements which signal the HTMU to provide heat management in response to abnormal electrical brain activity.
- Fig. 3 shows the components of the HTMU that analyze signals from the sensor elements and activate the heat pump when required.
- DESCRIPTION OF PREFERRED EMBODIMENTS An embodiment of the invention relates to hypothermia in combination with brain stimulation as a treatment of brain disorders, such as epilepsy. This may be accomplished by stimulating a brain structure which modulates seizures. Modulation is defined herein as increasing or decreasing neuronal excitability of a brain region responsible for producing seizures. Brain structures targeted for stimulation may be inhibitory or excitatory in nature. For example, the output of inhibitory structures, such as the cerebellum, thalamus, or brain stem, may be increased via brain stimulation to inhibit the firing of cells in a seizure focus located elsewhere.
- Another aspect of the invention is to target regions in which a treatment could directly block epileptogenic activity.
- targets include the hippocampus, the neocortex, and subcortical and brain stem regions.
- Different targets are expected to be important in different types of brain disorders. For example, patients having unilateral hippocampal onset epilepsy may consider hippocampal removal, but the surgery exposes some of these patients to potential memory impairment. Such patients may benefit from the lower risk hypothermia and electrical brain stimulation procedure of the invention. In other patients suffering from bilateral hippocampal disease, hypothermia and electrical stimulation might be an effective treatment, as unilateral hippocampal removal would not be useful and bilateral removal is not an option due to memory concerns.
- the hypothermia and brain stimulation treatment of the invention may be achieved by stimulating brain areas constantly, or at fixed intervals.
- Feedback driven stimulation from brain monitoring of seizure patterns or pre-seizure patterns is also suitable according to the invention, such that treatment to prevent perpetuation or spread of seizure patterns may be administered upon detection of seizure activity.
- altered neural discharges in the hippocampus, amygdala, neocortex or elsewhere may be present at the onset of a seizure. Such patterns often occur locally, but may spread before a seizure clinically manifests. These alterations could be detected and mitigated or eliminated with stimulation in combination with hypothermia. Patients often experience auras as perceived warnings of impending seizures.
- auras are very small seizures that do not progress to alter consciousness. Hypothermia and stimulation may block the spread of such auras. Consequently, a patient would be able to drive and engage in other normal daily activities. Stimulation may also interfere with synchronization of ictal firing. Synchronization or recruitment of multiple brain areas into a seizure pattern is very much related to the spread of seizure activity in the brain. Thus, either chronic stimulation or feedback-based episodic stimulation could impair synchronization and thus prevent seizure development.
- An aspect of the invention entails systematically evaluating neocortical ictal firing patterns and determining methods of interfering with these patterns. These patterns and activities have been extensively monitored through clinical epilepsy monitoring centers.
- Firing patterns differ among patients such that no one pattern can be expected to occur in all patients with epilepsy. Systematic evaluation of the firing pattern will allow optimization of treatment for each patient. Brain cell activity may be monitored by electrical or chemical sensing elements (activity sensing elements) contacting brain structures to detect abnormal neuronal firing patterns.
- Placement of the electrodes to target seizure foci similarly may be patient specific, according to the invention.
- EEG recordings indicate that some seizures begin at the cortical surface, while others originate deep within internal brain structures, such as the hippocampus, amygdala, and thalamus.
- seizures may occur as a purely subcortical phenomenon, most epileptologists believe seizures involve the cortex, but may be triggered by or may secondarily involve thalamo-cortical circuits.
- both cortical and subcortical stimulation could abort, or control, seizures, but different sites would have to be stimulated in different patients to be effective.
- subcortical regions such as the area tempesta and the caudate nucleus, have been found to be important areas for seizure initiation or propagation in some situations, and thus may be target areas for therapeutic intervention.
- the invention also provides for placement of a catheter or similar tubing into the brain for direct delivery of drugs to a seizure focus or a brain structure which modulates seizure activity.
- the direct infusion of drugs into the brain may reduce or prevent the occurrence of seizures.
- medication useful in the invention include such therapeutic agents as hydantoins, deoxybarbiturates, benzodiazepines, glutamate receptor agonists, glutamate receptor antagonists, ⁇ -aminobutyric acid receptor agonists, ⁇ -aminobutyric acid receptor antagonists, dopamine receptor agonists, dopamine receptor antagonists and anesthetics.
- Acute and chronic animal models of epilepsy such as kindling and cobalt/estrogen/penicilhn models, suggest that hypothermia combined ⁇ ith brain stimulation and/oi duect neuial drug infusion will successfully control brain disorders in humans.
- the invention provides for the control of brain disorders such as intractable pain, psychiatric disoiders and movement disorders Aliments including dystoma or tremor, manic-depressive illness, panic attacks and psychosis aie characterized b ⁇ aberrant neuronal activity, which may be alleviated by controlled hypothermia
- the implantable heat transfer device beha ⁇ es essentially as a controlled internal cold "compress".
- Cold therapy is well-know for the treatment of swelling and the invention provides for a finely regulated means for achieving cold therapy.
- swelling of brain or spinal tissue due to trauma, hemorrhage, encephalitis or localized myelitis, mass lesions, such as tumors, cysts, and abscesses may be reduced or eliminated by cooling of the affected tissue according to the ention
- intractable migraine headaches may be controlled by hypothermia according to the invention.
- the method for controlling brain or spinal tissue swelling and/or inflammation by controlled cooling would be executed essentially as described for brain cooling to regulate seizures.
- the method would comprise surgically cutting a heat transfer aperture into a patient's skull or spine, thereby exposing a predetermined portion of patient's brain or spinal coid
- a heat pump having one or more cell activity sensor elements and one or more tempeiature sensoi elements would be surgically implanted into said heat transfer aperture
- the heat transfei management unit would be attached such that a micro controller of the heat transfer management unit would be connected to one or more electrical sensor elements and one or more temperature sensor elements would contact brain or spinal cord tissue.
- the heat transfer management unit would be connected to said heat pump via a lead bundle. Responsive to signals from one or more sensor elements, mathematical algorithms of the heat transfer management unit would determine abnormal brain or spinal cord activity, causing the heat pump to transfer heat from the brain or spinal cord to a heat sink, thereby effecting cooling
- the invention is envisioned as a means to control swelling, inflammation or localized pain in non-central nervous system organs.
- Regionally or locally directed cooling to thoracic and abdominal organs, including the liver and intestine, as well as to skeletal muscle may control pain, swelling, or inflammation associated with these organs
- a heat pump and a heat transfer management unit may be surgically implanted in. for example, a patient ' s abdomen, utilizing essentially the same methodology described herein for directed brain hypothermia. Briefly, the procedure would be initiated by cutting an incision into a patient's musculature, fascia and body cavity linings and skin, thereby exposing a predetermined portion of said organ.
- a heat pump having one or more activity sensor elements and one or more temperature sensor elements would be surgically implanting through this incision.
- a heat transfer management unit would be attached such that a micro controller of the heat transfer management unit is connected to one or more activity sensor elements and one or more temperature sensor elements in contact with organ tissue.
- a lead bundle would connect the heat transfer management unit to said heat pump.
- mathematical algorithms of the heat transfer management unit detect abnormal organ cell activity Such abnormal activity causes the micro controller in the heat transfer management unit to direct the heat pump to initiate cooling to quash, for example, nociceptor activity associated with swelling, inflammation and pain.
- the invention is also envisioned as a method of controllably warming a hypothermic brain. Warming may be accomplished by heat transfer to brain tissue using a surgically implanted heat transfer and detection apparatus essentially as described hereinabove for brain cooling. Abnormally low brain cell firing may be detected and monitored by electrical sensor units implanted into a hypothermic brain.
- the heat transfer management unit may be surgically implanted into a patient's body cavity, or may optionally be located external to a patient's body. Responsive to signals from one or more electrical sensor elements, mathematical algorithms of the heat transfer management unit would determine abnormal brain activity, causing the heat pump to transfer heat to the brain tissue from a heat source, thereby heating the patient's brain.
- the advantage of this method would be to permit controllable warming based upon the level of brain activity, and would avoid overheating or warming a hypothermic brain too rapidly. Such treatments could be of use either in the setting of environmental or surgical hypothermia.
- Fig. 1 heat pump 1 is shown placed in a HTA surgically cut into the patient's skull.
- the heat pump has sensor elements 4 and 18 for detecting abnormal brain activity and brain surface temperature, respectively. The relationship between these components is detailed in Fig. 2.
- activity sensor elements 3 resting on the surface of the brain monitor background brain activity. Signals generated by activity sensor element 3 are used by the micro controller 22 __ (shown in Fig. 3) in the HTMU 8 to determine when cooling, and possibly heating, may be necessary for controlling seizures.
- One or more of sensor elements 3, 4, 18 may be present, depending upon the needs of the individual patient.
- Sensor elements 3a, 4a, 18a may extend to regions beneath the surface of the brain, when clinically advantageous. Thus, heat transfer may also be controlled by brain temperature as detected by sensors implanted within the brain.
- Heat pump 1 has leads 2 that connect to a lead bundle 7, which, in turn, connects to the HTMU 8. Electrical and temperature sensor leads 5, 6, 19 feed into a lead bundle 7 that in turn connects to the HTMU 8.
- the HTMU 8 may be implanted in the patient's abdomen, a subcutaneous pocket, or a subclavicular pocket.
- Heat sink 9 is comprises a sac of high heat conductivity compound, such as silicon oxide paste.
- the heat sink sac comprises a thin, biologically inert flexible material that permits substantial heat flow.
- Heat sink 9 covers a larger area than the HTA, thereby allowing heat dissipation from the body through a large part of the scalp.
- the large area in relation to the HTA and high thermal conductivity of the sink enable more heat to dissipate from the body for a given increase in temperature output from heat pump 1 than would otherwise occur. This configuration, in turn, improves the efficiency of the heat pump 1. Details of heat pump 1 are shown in Fig. 2. A solid state heat pump using the Peltier effect is illustrated.
- Peltier junctions 13,15,16 and 16,14,13 are sandwiched between two ceramic plates 17, 12 having high thermal conductivity. Electrical current passing through upper junctions 15 heats these junctions, while lower junctions 14 near the brain surface become cold. Thus, the Peltier effect pumps heat from the lower junctions to the upper junctions away from the brain to effect cooling. Reversal of current direction causes heat flow to the brain. Complete assemblies of Peltier junction heat pumps are well known and are readily available.
- the electrical current for the heat pump 1 is supplied through leads 2 that are routed through lead bundle 7 that in turn connects t the HTMU 8. .
- activity sensors 4 and a temperature sensor 18 are added to the lower ceramic plate 17 resting on the brain surface.
- Activity sensors 4 have leads 6 connecting the sensors to lead bundle 7, which in turn connects to the HTMU 8.
- temperature sensor 18 has a lead 19, that is routed to lead bundle 7 and thereafter to the HTMU 8.
- Activity sensors 4 exhibit dual functions in that they may provide electrical stimulation to the brain as well as sensing electrical brain activity. Electrical stimulation occurs together with heat pumping to control seizures. Temperature sensor 18 serves two functions.
- temperature sensor 18 may trigger heat pumping to prevent a seizure should brain temperature indicate a seizure is imminent.
- temperature sensor 18 regulates the amount of heat pumping achieved to prevent tissue damage. Although brain cooling is generally neuro-protective, too much brain cooling may result in tissue damage.
- HTMU 8 The details of the HTMU 8 are show in Fig. 3. Sensor signal leads 5, 6,19 are fed to amplifiers 20 , and then connect to analog to digital converter 21. Micro controller 22 then analyzes the digital representations of the sensor signals. When a seizure appears imminent, the micro controller 22 operates a solid state switch (SSW) 24 to feed power to heat pump 1, thereby preventing a seizure from occurring. Micro controller 22 uses a variable mark space waveform 26 to operate the SSW. This configuration allows variable levels of power to be applied to the heat pump while at the same time reducing the power wasted in the regulating element. SSW 24. Power source 25 is contained in the HTMU 8 and may comprise a primary battery or a rechargeable cell.
- SSW solid state switch
- Additional power may be provided by a subcutaneous coil or induction loop 10, connected to loop receiver 23 in the HTMU 8 by lead 11.
- Loop receiver 23 serves to direct additional power from the induction loop, and commands and configures changes for micro controller 22.
- the additional power and/or commands and configuration changes come from an external unit that would transmitted by magnetic induction. Data may also be transmitted from the implanted device to the external unit in a similar fashion.
- Seizures may be controlled by electrical stimulation, drug infusion or both combined with heat pumping. Electrical stimulation or infusion of therapeutic agent may be directed to any brain area associated with seizures, including the neocortex, hippocampus, amygdala thalamus, hypothalamus, caudate or other nuclei of the basal ganglia, cerebellum and brain stem.
- Stimulation switch 27 is provided for this purpose, according to the invention.
- Switch 27 is activated by micro controller 22. which sends a current pulse through lead 6 to activitv sensing electrode 4. Medications could be delivered to the brain via an implanted catheter or similar tubing in the same manner. Accordingly, switch 27 is activated by micro controller 22 and in turn initiates delivery a quantity of medication through tubing onto or into the brain
- Switch 27 could be a single, multipurpose switch or may be several switches, one for each purpose of initiating electrical stimulation and initiating medication delivery.
- EACC1 antisense DNA was continuously infused into the left ventricle of a test animal for 10 days using a pump located on the animal's back. Diffuse glutamate toxicity is thereby effected in the brain of the knockout rat. Diffuse glutamate activity produced seizures, manifested by activity arrest, staring, and rhythmic 2-3/sec epileptiform EEG patterns, all indicative of seizure activity. Thereafter, the test animal was anesthetized and a cooling unit adhered to the rat's head. Due to the thinness of rat crania, cooling of the brain was achieved through the intact rat skull. EEG tracings were made at baseline (28.8°C) and hypothermic (25.2°Q temperatures of the conscious rat. An overall reduction in seizure activity was observed after cooling, marked by the return of normal exploratory behavior and normal EEG tracings.
- ANNEGERS JF ( 1998) Demographics and Cost of Epilepsy. The American J of Managed Care, 4, S453-S462. 2. BATTISTA AF ( 1967) Effect of Cold on Cortical Potentials in Cats. Experimental Neurology, 19, 140- 155.
- FISHER RS UEMATSU S. KRAUSS GL. CYSYK BJ, LESSER RP, RISE M (1992) A Controlled Pilot Study of Centromedian Thalamic Stimulation for Epilepsy. Epilepsia, 33, 841-851.
- GOTMAN J LEVTOVA V (1996) Amygdala-Hippocampus Relationships in Temporal Lobe Seizures: A Phase-Coherence Study. Epilepsy Research, 25, 51-57.
- MIRSKI MA ROSSELL LA
- TERRY JB TERRY JB
- FISHER RS 1997) Anticonvulsant Effect of Anterior Thalamic High Frequency Electrical Stimulation in the Rat. Epilepsy Research, 28, 89-100.
- MIRSKI MA MIRSKI MA
- FERRENDELLI JA (1986) Selective Metabolic Activation of the Mammillary Bodies and Their Connections During Ethosuximide-Induced Suppression of Pentylenetetrazol Seizures. Epilepsia, 27. 194-203.
- VASTOLA EF HOMAN R, ROSEN A (1969) Inhibition of Focial Seizures by Moderate Hypothermia. Archives of Neurology, 20, 430-439.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69921449T DE69921449T2 (en) | 1998-01-12 | 1999-01-12 | METHOD FOR THE TREATMENT OF HORN DRESSES BY MEANS OF CONTROLLED HEAT SUPPLY |
AT99903007T ATE280555T1 (en) | 1998-01-12 | 1999-01-12 | METHOD FOR TREATING BRAIN DISEASE USING CONTROLLED HEAT SUPPLY |
CA002318243A CA2318243A1 (en) | 1998-01-12 | 1999-01-12 | Technique for using brain heat flow management to treat brain disorders |
EP99903007A EP1047362B1 (en) | 1998-01-12 | 1999-01-12 | Technique for using brain heat flow management to treat brain disorders |
AU23128/99A AU754269B2 (en) | 1998-01-12 | 1999-01-12 | Technique for using brain heat flow management to treat brain disorders |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7131298P | 1998-01-12 | 1998-01-12 | |
US60/071,312 | 1998-01-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999034758A1 true WO1999034758A1 (en) | 1999-07-15 |
Family
ID=22100543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/000374 WO1999034758A1 (en) | 1998-01-12 | 1999-01-12 | Technique for using brain heat flow management to treat brain disorders |
Country Status (8)
Country | Link |
---|---|
US (1) | US6248126B1 (en) |
EP (1) | EP1047362B1 (en) |
AT (1) | ATE280555T1 (en) |
AU (1) | AU754269B2 (en) |
CA (1) | CA2318243A1 (en) |
DE (1) | DE69921449T2 (en) |
ES (1) | ES2234235T3 (en) |
WO (1) | WO1999034758A1 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002028330A1 (en) * | 2000-10-05 | 2002-04-11 | Seacoast Technologies, Inc. | Neurosurgical device for thermal therapy |
WO2001076517A3 (en) * | 2000-04-07 | 2002-05-23 | Gen Hospital Corp | Methods and apparatus for thermally affecting tissue |
WO2003005797A2 (en) | 2001-07-13 | 2003-01-23 | Ad-Tech Medical Instrument Corp. | Heat-removal method and apparatus for treatment of movement disorder episodes |
EP1870131A1 (en) * | 2005-04-12 | 2007-12-26 | National University Corporation Nagoya University | Ventricular fibrillation preventing device and ventricular fibrillation removing device |
WO2008121231A2 (en) * | 2007-03-29 | 2008-10-09 | Cardiac Pacemakers, Inc. | Systems and leads for thermal neuroinhibition |
US9084901B2 (en) | 2006-04-28 | 2015-07-21 | Medtronic, Inc. | Cranial implant |
US9162072B2 (en) | 2004-04-30 | 2015-10-20 | Medtronic, Inc. | Implantable medical device with lubricious material |
US9393432B2 (en) | 2008-10-31 | 2016-07-19 | Medtronic, Inc. | Non-hermetic direct current interconnect |
US9522081B2 (en) | 2008-12-02 | 2016-12-20 | University Of Washington | Methods and devices for brain cooling for treatment and/or prevention of epileptic seizures |
EP3263076A1 (en) * | 2016-06-07 | 2018-01-03 | Universidade do Minho | Implantable thermal neuromodulator with wireless powering and wireless communications and fabrication method thereof |
US11253729B2 (en) | 2016-03-11 | 2022-02-22 | Sorbonne Universite | External ultrasound generating treating device for spinal cord and/or spinal nerve treatment, apparatus comprising such device and method |
US11420078B2 (en) | 2016-03-11 | 2022-08-23 | Sorbonne Universite | Implantable ultrasound generating treating device for spinal cord and/or spinal nerve treatment, apparatus comprising such device and method |
US11738214B2 (en) | 2014-12-19 | 2023-08-29 | Sorbonne Universite | Implantable ultrasound generating treating device for brain treatment, apparatus comprising such device and method implementing such device |
Families Citing this family (187)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7440800B2 (en) * | 1996-08-19 | 2008-10-21 | Mr3 Medical, Llc | System and method for managing detrimental cardiac remodeling |
US7908003B1 (en) | 1996-08-19 | 2011-03-15 | Mr3 Medical Llc | System and method for treating ischemia by improving cardiac efficiency |
US8447399B2 (en) * | 1996-08-19 | 2013-05-21 | Mr3 Medical, Llc | System and method for managing detrimental cardiac remodeling |
US7203537B2 (en) * | 1996-08-19 | 2007-04-10 | Mr3 Medical, Llc | System and method for breaking reentry circuits by cooling cardiac tissue |
US7840264B1 (en) | 1996-08-19 | 2010-11-23 | Mr3 Medical, Llc | System and method for breaking reentry circuits by cooling cardiac tissue |
US7974696B1 (en) | 1998-08-05 | 2011-07-05 | Dilorenzo Biomedical, Llc | Closed-loop autonomic neuromodulation for optimal control of neurological and metabolic disease |
US7231254B2 (en) * | 1998-08-05 | 2007-06-12 | Bioneuronics Corporation | Closed-loop feedback-driven neuromodulation |
US9375573B2 (en) | 1998-08-05 | 2016-06-28 | Cyberonics, Inc. | Systems and methods for monitoring a patient's neurological disease state |
US7209787B2 (en) | 1998-08-05 | 2007-04-24 | Bioneuronics Corporation | Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease |
US9415222B2 (en) | 1998-08-05 | 2016-08-16 | Cyberonics, Inc. | Monitoring an epilepsy disease state with a supervisory module |
US9042988B2 (en) | 1998-08-05 | 2015-05-26 | Cyberonics, Inc. | Closed-loop vagus nerve stimulation |
US7747325B2 (en) | 1998-08-05 | 2010-06-29 | Neurovista Corporation | Systems and methods for monitoring a patient's neurological disease state |
US9320900B2 (en) | 1998-08-05 | 2016-04-26 | Cyberonics, Inc. | Methods and systems for determining subject-specific parameters for a neuromodulation therapy |
US8762065B2 (en) | 1998-08-05 | 2014-06-24 | Cyberonics, Inc. | Closed-loop feedback-driven neuromodulation |
GB0007193D0 (en) * | 2000-03-25 | 2000-05-17 | Univ Manchester | Treatment of movrmrnt disorders |
US20040034321A1 (en) * | 2000-10-05 | 2004-02-19 | Seacoast Technologies, Inc. | Conformal pad for neurosurgery and method thereof |
US6678548B1 (en) | 2000-10-20 | 2004-01-13 | The Trustees Of The University Of Pennsylvania | Unified probabilistic framework for predicting and detecting seizure onsets in the brain and multitherapeutic device |
US6648880B2 (en) | 2001-02-16 | 2003-11-18 | Cryocath Technologies Inc. | Method of using cryotreatment to treat brain tissue |
EP1249691A1 (en) * | 2001-04-11 | 2002-10-16 | Omron Corporation | Electronic clinical thermometer |
US6726709B1 (en) * | 2001-04-30 | 2004-04-27 | Medcool, Inc. | Method and device for reducing death and morbidity from stroke |
US6978183B2 (en) * | 2001-05-04 | 2005-12-20 | The Washington University | System and method for cooling the cortex to treat neocordical seizures |
US7094234B1 (en) * | 2001-08-27 | 2006-08-22 | Medcool, Inc. | Interstitial brain cooling probe and sheath apparatus |
US6688112B2 (en) | 2001-12-04 | 2004-02-10 | University Of Mississippi | Thermoacoustic refrigeration device and method |
US6746474B2 (en) * | 2002-05-31 | 2004-06-08 | Vahid Saadat | Apparatus and methods for cooling a region within the body |
US20040039430A1 (en) | 2002-08-20 | 2004-02-26 | Xanodyne Pharmacal, Inc. | System and method using the rectal mucosal membrane for inducing hypothermia and warming |
AU2003277349A1 (en) * | 2002-10-11 | 2004-05-04 | Flint Hills Scientific, L.L.C. | Multi-modal system for detection and control of changes in brain state |
WO2004032720A2 (en) * | 2002-10-11 | 2004-04-22 | Flint Hills Scientific, L.L.C. | Multi-modal system for detection and control of changes in brain state |
US7204833B1 (en) | 2002-10-11 | 2007-04-17 | Flint Hills Scientific Llc | Multi-modal system for detection and control of changes in brain state |
AU2003294595A1 (en) * | 2002-12-09 | 2004-06-30 | Medtronic, Inc. | Modular implantable medical device |
US7596408B2 (en) * | 2002-12-09 | 2009-09-29 | Medtronic, Inc. | Implantable medical device with anti-infection agent |
US7004961B2 (en) * | 2003-01-09 | 2006-02-28 | Edward Wong | Medical device and method for temperature control and treatment of the brain and spinal cord |
US7317947B2 (en) * | 2003-05-16 | 2008-01-08 | Medtronic, Inc. | Headset recharger for cranially implantable medical devices |
US20050003268A1 (en) * | 2003-05-16 | 2005-01-06 | Scott Erik R. | Battery housing configuration |
US20050004637A1 (en) * | 2003-05-16 | 2005-01-06 | Ruchika Singhal | Explantation of implantable medical device |
US7263401B2 (en) * | 2003-05-16 | 2007-08-28 | Medtronic, Inc. | Implantable medical device with a nonhermetic battery |
CA2432810A1 (en) | 2003-06-19 | 2004-12-19 | Andres M. Lozano | Method of treating depression, mood disorders and anxiety disorders by brian infusion |
EP3045136B1 (en) | 2003-09-12 | 2021-02-24 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US20050102006A1 (en) * | 2003-09-25 | 2005-05-12 | Whitehurst Todd K. | Skull-mounted electrical stimulation system |
WO2005062829A2 (en) * | 2003-12-19 | 2005-07-14 | Advanced Bionics Corporation | Skull-mounted electrical stimulation system and method for treating patients |
US7596399B2 (en) * | 2004-04-29 | 2009-09-29 | Medtronic, Inc | Implantation of implantable medical device |
EP1750800A1 (en) * | 2004-04-30 | 2007-02-14 | Advanced Neuromodulation Systems, Inc. | Method of treating mood disorders and/or anxiety disorders by brain stimulation |
US20050246000A1 (en) * | 2004-05-03 | 2005-11-03 | Seacoast Technologies, Inc. | Cooled craniectomy |
US7447541B2 (en) * | 2004-06-30 | 2008-11-04 | Instrumentarium Corporation | Monitoring subcortical responsiveness of a patient |
US8920414B2 (en) | 2004-09-10 | 2014-12-30 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US8672988B2 (en) * | 2004-10-22 | 2014-03-18 | Medtronic Cryocath Lp | Method and device for local cooling within an organ using an intravascular device |
US7306621B1 (en) | 2004-11-19 | 2007-12-11 | National Semiconductor Corporation | Heat transfer control for a prosthetic retinal device |
JP2008535538A (en) * | 2005-03-01 | 2008-09-04 | ファンクショナル ニューロサイエンス インコーポレイテッド | Methods for treating depression, mood disorders and anxiety disorders using neuromodulation |
WO2006094072A2 (en) * | 2005-03-01 | 2006-09-08 | Functional Neuroscience Inc. | Method of treating cognitive disorders using neuromodulation |
US7505816B2 (en) * | 2005-04-29 | 2009-03-17 | Medtronic, Inc. | Actively cooled external energy source, external charger, system of transcutaneous energy transfer, system of transcutaneous charging and method therefore |
US7824436B2 (en) * | 2005-05-13 | 2010-11-02 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
US9358150B2 (en) | 2005-05-13 | 2016-06-07 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance |
US7572268B2 (en) * | 2005-10-13 | 2009-08-11 | Bacoustics, Llc | Apparatus and methods for the selective removal of tissue using combinations of ultrasonic energy and cryogenic energy |
US7842032B2 (en) | 2005-10-13 | 2010-11-30 | Bacoustics, Llc | Apparatus and methods for the selective removal of tissue |
US20070088386A1 (en) * | 2005-10-18 | 2007-04-19 | Babaev Eilaz P | Apparatus and method for treatment of soft tissue injuries |
US7729773B2 (en) * | 2005-10-19 | 2010-06-01 | Advanced Neuromodualation Systems, Inc. | Neural stimulation and optical monitoring systems and methods |
US8725243B2 (en) | 2005-12-28 | 2014-05-13 | Cyberonics, Inc. | Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders |
US8868172B2 (en) | 2005-12-28 | 2014-10-21 | Cyberonics, Inc. | Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders |
CA2649875C (en) | 2006-04-20 | 2014-11-18 | University Of Pittsburgh | Method and apparatus of noninvasive, regional brain thermal stimuli for the treatment of neurological disorders |
US11684510B2 (en) | 2006-04-20 | 2023-06-27 | University of Pittsburgh—of the Commonwealth System of Higher Education | Noninvasive, regional brain thermal stimuli for the treatment of neurological disorders |
US8425583B2 (en) | 2006-04-20 | 2013-04-23 | University of Pittsburgh—of the Commonwealth System of Higher Education | Methods, devices and systems for treating insomnia by inducing frontal cerebral hypothermia |
US9492313B2 (en) | 2006-04-20 | 2016-11-15 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Method and apparatus of noninvasive, regional brain thermal stimuli for the treatment of neurological disorders |
US9211212B2 (en) | 2006-04-20 | 2015-12-15 | Cerêve, Inc. | Apparatus and method for modulating sleep |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US20080027347A1 (en) | 2006-06-23 | 2008-01-31 | Neuro Vista Corporation, A Delaware Corporation | Minimally Invasive Monitoring Methods |
US20090221955A1 (en) * | 2006-08-08 | 2009-09-03 | Bacoustics, Llc | Ablative ultrasonic-cryogenic methods |
US20080039727A1 (en) * | 2006-08-08 | 2008-02-14 | Eilaz Babaev | Ablative Cardiac Catheter System |
EP2076194B1 (en) | 2006-10-18 | 2013-04-24 | Vessix Vascular, Inc. | System for inducing desirable temperature effects on body tissue |
EP2992850A1 (en) | 2006-10-18 | 2016-03-09 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
US8295934B2 (en) | 2006-11-14 | 2012-10-23 | Neurovista Corporation | Systems and methods of reducing artifact in neurological stimulation systems |
EP2126785A2 (en) | 2007-01-25 | 2009-12-02 | NeuroVista Corporation | Systems and methods for identifying a contra-ictal condition in a subject |
US20080183097A1 (en) | 2007-01-25 | 2008-07-31 | Leyde Kent W | Methods and Systems for Measuring a Subject's Susceptibility to a Seizure |
US8036736B2 (en) | 2007-03-21 | 2011-10-11 | Neuro Vista Corporation | Implantable systems and methods for identifying a contra-ictal condition in a subject |
US8202308B2 (en) * | 2007-06-29 | 2012-06-19 | Matthew D. Smyth | Depth cooling implant system |
US9788744B2 (en) | 2007-07-27 | 2017-10-17 | Cyberonics, Inc. | Systems for monitoring brain activity and patient advisory device |
US8738139B2 (en) | 2007-08-01 | 2014-05-27 | Bruce Lanning | Wireless system for epilepsy monitoring and measurement |
DE102007046694A1 (en) * | 2007-09-28 | 2009-04-09 | Raumedic Ag | Sensor system for measuring, transmitting, processing and displaying a brain parameter |
US8989858B2 (en) | 2007-12-05 | 2015-03-24 | The Invention Science Fund I, Llc | Implant system for chemical modulation of neural activity |
US8170658B2 (en) * | 2007-12-05 | 2012-05-01 | The Invention Science Fund I, Llc | System for electrical modulation of neural conduction |
US20090149797A1 (en) * | 2007-12-05 | 2009-06-11 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | System for reversible chemical modulation of neural activity |
US8170659B2 (en) * | 2007-12-05 | 2012-05-01 | The Invention Science Fund I, Llc | Method for thermal modulation of neural activity |
US8165669B2 (en) * | 2007-12-05 | 2012-04-24 | The Invention Science Fund I, Llc | System for magnetic modulation of neural conduction |
US8195287B2 (en) * | 2007-12-05 | 2012-06-05 | The Invention Science Fund I, Llc | Method for electrical modulation of neural conduction |
US8165668B2 (en) * | 2007-12-05 | 2012-04-24 | The Invention Science Fund I, Llc | Method for magnetic modulation of neural conduction |
US8180446B2 (en) * | 2007-12-05 | 2012-05-15 | The Invention Science Fund I, Llc | Method and system for cyclical neural modulation based on activity state |
US8180447B2 (en) | 2007-12-05 | 2012-05-15 | The Invention Science Fund I, Llc | Method for reversible chemical modulation of neural activity |
WO2009073891A1 (en) * | 2007-12-07 | 2009-06-11 | Northstar Neuroscience, Inc. | Systems and methods for providing targeted neural stimulation therapy to address neurological disorders, including neuropyschiatric and neuropyschological disorders |
US20090171168A1 (en) | 2007-12-28 | 2009-07-02 | Leyde Kent W | Systems and Method for Recording Clinical Manifestations of a Seizure |
US9259591B2 (en) | 2007-12-28 | 2016-02-16 | Cyberonics, Inc. | Housing for an implantable medical device |
EP2271275B1 (en) | 2008-05-05 | 2012-06-27 | Stryker Corporation | Powered surgical tool with a memory, conductors over which power and memory interrogation signals are applied to the tool and an isolation circuit that prevents the power signals from adversely affecting the memory |
US8713026B2 (en) * | 2008-06-13 | 2014-04-29 | Sandisk Technologies Inc. | Method for playing digital media files with a digital media player using a plurality of playlists |
CA2743992A1 (en) | 2008-11-17 | 2010-05-20 | Minnow Medical, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
US8591562B2 (en) * | 2008-12-02 | 2013-11-26 | University Of Washington | Methods and devices for brain cooling for treatment and prevention of acquired epilepsy |
US8849390B2 (en) | 2008-12-29 | 2014-09-30 | Cyberonics, Inc. | Processing for multi-channel signals |
US8588933B2 (en) | 2009-01-09 | 2013-11-19 | Cyberonics, Inc. | Medical lead termination sleeve for implantable medical devices |
US8786624B2 (en) | 2009-06-02 | 2014-07-22 | Cyberonics, Inc. | Processing for multi-channel signals |
US9643019B2 (en) | 2010-02-12 | 2017-05-09 | Cyberonics, Inc. | Neurological monitoring and alerts |
WO2011101039A1 (en) | 2010-02-22 | 2011-08-25 | Universite Pierre Et Marie Curie (Paris 6) | Apparatus for the treatment of brain affections and method implementing thereof |
CN103068330B (en) | 2010-04-09 | 2016-06-29 | Vessix血管股份有限公司 | Power for treating tissue occurs and controls device |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
RU2454197C1 (en) * | 2010-12-29 | 2012-06-27 | Общество с ограниченной ответственностью "Центрмед-М" | Device for hypothermia induction (versions) |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
CN103813745B (en) | 2011-07-20 | 2016-06-29 | 波士顿科学西美德公司 | In order to visualize, be directed at and to melt transcutaneous device and the method for nerve |
CN103813829B (en) | 2011-07-22 | 2016-05-18 | 波士顿科学西美德公司 | There is the neuromodulation system of the neuromodulation element that can be positioned in spiral guiding piece |
EP2736468B1 (en) | 2011-07-27 | 2016-04-27 | Université Pierre et Marie Curie (Paris 6) | Device for treating the sensory capacity of a person |
WO2013055826A1 (en) | 2011-10-10 | 2013-04-18 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US10085799B2 (en) | 2011-10-11 | 2018-10-02 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
EP2768563B1 (en) | 2011-10-18 | 2016-11-09 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
EP2768568B1 (en) | 2011-10-18 | 2020-05-06 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
CN108095821B (en) | 2011-11-08 | 2021-05-25 | 波士顿科学西美德公司 | Orifice renal nerve ablation |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
EP2793724B1 (en) | 2011-12-23 | 2016-10-12 | Vessix Vascular, Inc. | Apparatuses for remodeling tissue of or adjacent to a body passage |
CN104135958B (en) | 2011-12-28 | 2017-05-03 | 波士顿科学西美德公司 | By the apparatus and method that have the new ablation catheter modulation nerve of polymer ablation |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
WO2013169927A1 (en) | 2012-05-08 | 2013-11-14 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
CN104540465A (en) | 2012-08-24 | 2015-04-22 | 波士顿科学西美德公司 | Intravascular catheter with a balloon comprising separate microporous regions |
WO2014039925A2 (en) | 2012-09-07 | 2014-03-13 | Yale University | Brian cooling system |
CN104780859B (en) | 2012-09-17 | 2017-07-25 | 波士顿科学西美德公司 | Self-positioning electrode system and method for renal regulation |
WO2014047411A1 (en) | 2012-09-21 | 2014-03-27 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
WO2014107509A1 (en) | 2013-01-02 | 2014-07-10 | Cerêve, Inc. | Systems for enhancing sleep |
US11752356B2 (en) | 2013-03-11 | 2023-09-12 | NeuroEM Therapeutics, Inc. | Systems for controlling power to differently loaded antenna arrays |
US11759650B2 (en) | 2013-03-11 | 2023-09-19 | NeuroEM Therapeutics, Inc. | Immunoregulation, brain detoxification, and cognitive protection by electromagnetic treatment |
US11813472B2 (en) | 2013-03-11 | 2023-11-14 | NeuroEM Therapeutics, Inc. | Systems for sensing proper emitter array placement |
WO2014163987A1 (en) | 2013-03-11 | 2014-10-09 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US11911629B2 (en) | 2013-03-11 | 2024-02-27 | NeurEM Therapeutics, Inc. | Treatment of primary and metastatic brain cancers by transcranial electromagnetic treatment |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
JP6220044B2 (en) | 2013-03-15 | 2017-10-25 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device for renal nerve ablation |
US9297845B2 (en) | 2013-03-15 | 2016-03-29 | Boston Scientific Scimed, Inc. | Medical devices and methods for treatment of hypertension that utilize impedance compensation |
US10022182B2 (en) | 2013-06-21 | 2018-07-17 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
JP2016523147A (en) | 2013-06-21 | 2016-08-08 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Renal denervation balloon catheter with a riding-type electrode support |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
WO2015002787A1 (en) | 2013-07-01 | 2015-01-08 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10413357B2 (en) | 2013-07-11 | 2019-09-17 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
EP3019105B1 (en) | 2013-07-11 | 2017-09-13 | Boston Scientific Scimed, Inc. | Devices for nerve modulation |
CN105682594B (en) | 2013-07-19 | 2018-06-22 | 波士顿科学国际有限公司 | Helical bipolar electrodes renal denervation dominates air bag |
EP3024405A1 (en) | 2013-07-22 | 2016-06-01 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
EP3024406B1 (en) | 2013-07-22 | 2019-06-19 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
WO2015027096A1 (en) | 2013-08-22 | 2015-02-26 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
EP3043733A1 (en) | 2013-09-13 | 2016-07-20 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
EP3057521B1 (en) | 2013-10-18 | 2020-03-25 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires |
US10271898B2 (en) | 2013-10-25 | 2019-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
EP3091922B1 (en) | 2014-01-06 | 2018-10-17 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
EP3424453A1 (en) | 2014-02-04 | 2019-01-09 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
ES2726653T3 (en) * | 2014-03-11 | 2019-10-08 | Oregon Health & Science Univ Office Of Technology Transfer And Business Development | Placement and stimulation of a deep brain electrode based on the temperature of brown adipose tissue |
US11794028B2 (en) * | 2014-03-11 | 2023-10-24 | NeuroEM Therapeutics, Inc. | Transcranial electromagnetic treatment |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
AU2016316683B2 (en) | 2015-09-04 | 2020-07-23 | The Johns Hopkins University | Low-profile intercranial device |
US10912648B2 (en) | 2016-08-30 | 2021-02-09 | Longeviti Neuro Solutions Llc | Method for manufacturing a low-profile intercranial device and the low-profile intercranial device manufactured thereby |
US20180318579A1 (en) | 2017-05-06 | 2018-11-08 | Smartimplantsystems, Inc. | Active implantable medical device associated with, or integrated into, an orthopedic implant device |
US11723579B2 (en) | 2017-09-19 | 2023-08-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement |
US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
US11478603B2 (en) | 2017-12-31 | 2022-10-25 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
US11589992B2 (en) | 2018-01-09 | 2023-02-28 | Longeviti Neuro Solutions Llc | Universal low-profile intercranial assembly |
FR3078879B1 (en) | 2018-03-14 | 2020-03-06 | Assistance Publique Hopitaux De Paris | SURGICAL KIT TO BE USED DURING A CRANIECTOMY PROCEDURE |
US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
CN113382683A (en) | 2018-09-14 | 2021-09-10 | 纽罗因恒思蒙特实验有限责任公司 | System and method for improving sleep |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4989601A (en) * | 1988-05-02 | 1991-02-05 | Medical Engineering & Development Institute, Inc. | Method, apparatus, and substance for treating tissue having neoplastic cells |
US5540737A (en) * | 1991-06-26 | 1996-07-30 | Massachusetts Institute Of Technology | Minimally invasive monopole phased array hyperthermia applicators and method for treating breast carcinomas |
US5611767A (en) * | 1991-06-14 | 1997-03-18 | Oncocath, Inc. | Radiation treatment of tumors using inflatable devices |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3170465A (en) * | 1962-06-26 | 1965-02-23 | James E Henney | Internal body heating devices |
EP0165523B1 (en) * | 1981-03-28 | 1989-05-24 | Yoshiro Nakamatsu | Apparatus for measuring brain activity |
EP0132276B1 (en) * | 1983-01-21 | 1991-08-14 | Ramm Associates | Implantable hyperthermia device and system |
US5995868A (en) * | 1996-01-23 | 1999-11-30 | University Of Kansas | System for the prediction, rapid detection, warning, prevention, or control of changes in activity states in the brain of a subject |
US5916242A (en) * | 1996-11-04 | 1999-06-29 | Schwartz; George R. | Apparatus for rapid cooling of the brain and method of performing same |
-
1999
- 1999-01-12 DE DE69921449T patent/DE69921449T2/en not_active Expired - Fee Related
- 1999-01-12 AU AU23128/99A patent/AU754269B2/en not_active Ceased
- 1999-01-12 US US09/228,414 patent/US6248126B1/en not_active Expired - Lifetime
- 1999-01-12 ES ES99903007T patent/ES2234235T3/en not_active Expired - Lifetime
- 1999-01-12 WO PCT/US1999/000374 patent/WO1999034758A1/en active IP Right Grant
- 1999-01-12 EP EP99903007A patent/EP1047362B1/en not_active Expired - Lifetime
- 1999-01-12 AT AT99903007T patent/ATE280555T1/en not_active IP Right Cessation
- 1999-01-12 CA CA002318243A patent/CA2318243A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4989601A (en) * | 1988-05-02 | 1991-02-05 | Medical Engineering & Development Institute, Inc. | Method, apparatus, and substance for treating tissue having neoplastic cells |
US5611767A (en) * | 1991-06-14 | 1997-03-18 | Oncocath, Inc. | Radiation treatment of tumors using inflatable devices |
US5540737A (en) * | 1991-06-26 | 1996-07-30 | Massachusetts Institute Of Technology | Minimally invasive monopole phased array hyperthermia applicators and method for treating breast carcinomas |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001076517A3 (en) * | 2000-04-07 | 2002-05-23 | Gen Hospital Corp | Methods and apparatus for thermally affecting tissue |
US6849072B2 (en) | 2000-04-07 | 2005-02-01 | The General Hospital Corporation | Methods and apparatus for thermally affecting tissue |
WO2002028329A1 (en) * | 2000-10-05 | 2002-04-11 | Seacoast Technologies, Inc. | Neurosurgical device for thermal therapy including spiral element |
WO2002028330A1 (en) * | 2000-10-05 | 2002-04-11 | Seacoast Technologies, Inc. | Neurosurgical device for thermal therapy |
EP1407090A4 (en) * | 2001-07-13 | 2008-12-10 | Ad Tech Medical Instr Corp | Heat-removal method and apparatus for treatment of movement disorder episodes |
WO2003005797A2 (en) | 2001-07-13 | 2003-01-23 | Ad-Tech Medical Instrument Corp. | Heat-removal method and apparatus for treatment of movement disorder episodes |
EP1407090A2 (en) * | 2001-07-13 | 2004-04-14 | Ad-Tech Medical Instrument Corporation | Heat-removal method and apparatus for treatment of movement disorder episodes |
US9162072B2 (en) | 2004-04-30 | 2015-10-20 | Medtronic, Inc. | Implantable medical device with lubricious material |
EP1870131A4 (en) * | 2005-04-12 | 2009-10-21 | Univ Nagoya Nat Univ Corp | Ventricular fibrillation preventing device and ventricular fibrillation removing device |
EP1870131A1 (en) * | 2005-04-12 | 2007-12-26 | National University Corporation Nagoya University | Ventricular fibrillation preventing device and ventricular fibrillation removing device |
US9504402B2 (en) | 2006-04-28 | 2016-11-29 | Medtronic, Inc. | Cranial implant |
US9084901B2 (en) | 2006-04-28 | 2015-07-21 | Medtronic, Inc. | Cranial implant |
US8734499B2 (en) | 2007-03-29 | 2014-05-27 | Cardiac Pacemakers, Inc. | Systems and methods for thermal neuroinhibition |
WO2008121231A2 (en) * | 2007-03-29 | 2008-10-09 | Cardiac Pacemakers, Inc. | Systems and leads for thermal neuroinhibition |
WO2008121231A3 (en) * | 2007-03-29 | 2008-12-18 | Cardiac Pacemakers Inc | Systems and leads for thermal neuroinhibition |
US9393432B2 (en) | 2008-10-31 | 2016-07-19 | Medtronic, Inc. | Non-hermetic direct current interconnect |
US9522081B2 (en) | 2008-12-02 | 2016-12-20 | University Of Washington | Methods and devices for brain cooling for treatment and/or prevention of epileptic seizures |
US10517755B2 (en) | 2008-12-02 | 2019-12-31 | University Of Washington | Methods and devices for brain cooling for treatment and/or prevention of epileptic seizures |
US11738214B2 (en) | 2014-12-19 | 2023-08-29 | Sorbonne Universite | Implantable ultrasound generating treating device for brain treatment, apparatus comprising such device and method implementing such device |
US11253729B2 (en) | 2016-03-11 | 2022-02-22 | Sorbonne Universite | External ultrasound generating treating device for spinal cord and/or spinal nerve treatment, apparatus comprising such device and method |
US11420078B2 (en) | 2016-03-11 | 2022-08-23 | Sorbonne Universite | Implantable ultrasound generating treating device for spinal cord and/or spinal nerve treatment, apparatus comprising such device and method |
US11771925B2 (en) | 2016-03-11 | 2023-10-03 | Sorbonne Universite | Implantable ultrasound generating treating device for spinal cord and/or spinal nerve treatment, apparatus comprising such device and method |
EP3263076A1 (en) * | 2016-06-07 | 2018-01-03 | Universidade do Minho | Implantable thermal neuromodulator with wireless powering and wireless communications and fabrication method thereof |
Also Published As
Publication number | Publication date |
---|---|
ATE280555T1 (en) | 2004-11-15 |
AU754269B2 (en) | 2002-11-07 |
EP1047362B1 (en) | 2004-10-27 |
EP1047362A4 (en) | 2002-06-05 |
ES2234235T3 (en) | 2005-06-16 |
AU2312899A (en) | 1999-07-26 |
CA2318243A1 (en) | 1999-07-15 |
EP1047362A1 (en) | 2000-11-02 |
DE69921449T2 (en) | 2005-11-24 |
DE69921449D1 (en) | 2004-12-02 |
US6248126B1 (en) | 2001-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU754269B2 (en) | Technique for using brain heat flow management to treat brain disorders | |
US6882881B1 (en) | Techniques using heat flow management, stimulation, and signal analysis to treat medical disorders | |
Morrell | Brain stimulation for epilepsy: can scheduled or responsive neurostimulation stop seizures? | |
Sun et al. | Responsive cortical stimulation for the treatment of epilepsy | |
US20220331581A1 (en) | Extracranial implantable devices, systems and methods for the treatment of neurological disorders | |
Jobst | Brain stimulation for surgical epilepsy | |
WO2001028622A2 (en) | Techniques using heat flow management, stimulation, and signal analysis to treat medical disorders | |
Al-Otaibi et al. | Neuromodulation in epilepsy | |
Lim et al. | Electrical stimulation of the anterior nucleus of the thalamus for intractable epilepsy: a long‐term follow‐up study | |
Velasco et al. | Double‐blind, randomized controlled pilot study of bilateral cerebellar stimulation for treatment of intractable motor seizures | |
Benabid et al. | Antiepileptic effect of high-frequency stimulation of the subthalamic nucleus (corpus luysi) in a case of medically intractable epilepsy caused by focal dysplasia: a 30-month follow-up: technical case report | |
Vonck et al. | Long‐term amygdalohippocampal stimulation for refractory temporal lobe epilepsy | |
Motamedi et al. | Therapeutic brain hypothermia, its mechanisms of action, and its prospects as a treatment for epilepsy | |
US20080125830A1 (en) | Responsive Therapy for Psychiatric Disorders | |
Jobst | Electrical stimulation in epilepsy: vagus nerve and brain stimulation | |
Li et al. | Electrical control of epileptic seizures | |
Budnick et al. | Hypothermia-induced changes in rat short latency somatosensory evoked potentials | |
Fujii et al. | Application of focal cerebral cooling for the treatment of intractable epilepsy | |
Gigante et al. | Alternative surgical approaches in epilepsy | |
Herrera et al. | Stimulation of the anterior nucleus of the thalamus for epilepsy: a Canadian experience | |
Fauser et al. | Critical review of palliative surgical techniques for intractable epilepsy | |
Oommen et al. | Experimental electrical stimulation therapy for epilepsy | |
Löscher et al. | Commentary: physical approaches for the treatment of epilepsy: electrical and magnetic stimulation and cooling | |
Marino Jr et al. | Selective electroencephalograph-guided microsurgical callosotomy for refractory generalized epilepsy | |
Montes et al. | Cognitive effects of precentral cortical stimulation for pain control: an ERP study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2318243 Country of ref document: CA Kind code of ref document: A Ref document number: 2318243 |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999903007 Country of ref document: EP Ref document number: 23128/99 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 1999903007 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 23128/99 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 1999903007 Country of ref document: EP |